Company intelligence / Profile preview

Zinzino

Ownership: Private
Development stage: Commercial

Overview

Zinzino offers a commercial portfolio of scientifically validated, test-based nutritional supplements and biotech skincare products. Their approach includes home blood tests for personalized nutrition recommendations. The company reports strong revenue growth and global expansion, but does not conduct traditional drug clinical trials[4][5][6].

Therapeutic areas: OtherDermatologyImmunologyGastroenterology
Modalities: Nutritional supplementBiologicDevice
Industry: Food & Nutrition

Drug pipeline

2 assets

BalanceOil+

Commercial

Indications: Omega-3 deficiency

1 more asset in the full pipeline.

Request access →

Partnerships

Collaboration with world leader in dried blood spot testing for lab analysis of home tests

Beyond the preview

Go deeper on Zinzino.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinzino.

Explore the full profile